Public COA audit

Semaglutide

Audited July 28, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
72
Confidence
83%
Panels
2/7
Purity (printed)
99.83%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
GS10-10142025-H
Identity method
HPLC with UV Detection Coupled with Mass Spectrometry
Sample date
2025-10-15
Issue date
2025-10-16

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

2 of 7 present · 2 passed · 0 failed · 0 reported · 5 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Semaglutide confirmed

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.83%

  • Heavy metals

    Not on this COA

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Not on this COA · core

    LAL or chromogenic endotoxin assay.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Sterility

    Not on this COA

    Sterility testing where applicable.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    99.83% purity by HPLC-MS is within normal range for research-grade peptides

  • Identity confirmed

    Mass spectrometry data shows expected molecular ion peaks [M+4H]4+ at 1029.03 and [M+3H]3+ at 1371.53, consistent with Semaglutide

  • Lab verification limited

    Freedom Diagnostics appears to be a smaller testing facility; independent verification of lab accreditation status not immediately available from document

  • Limited testing scope

    COA only includes identity and purity testing; no heavy metals, microbial, endotoxin, sterility, or residual solvent testing performed

  • Basic presentation

    Document formatting is relatively simple compared to major commercial testing labs, though this alone does not indicate fabrication

  • Batch information present

    Lot number GS10-10142025-H clearly stated with net peptide content of 12.27mg

  • Dates reasonable

    Received 2025-10-15, reported 2025-10-16 shows one-day turnaround, which is plausible for identity/purity testing only

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.